In 1985, Strom et al described two families in which rheumatoid arthritis (RA) appeared in several members over three consecutive generations.' Although these pedigrees taken alone could implicate dominant inheritance, the overall picture with RA pedigrees indicates a complex mode of inheritance, with incomplete penetrance of predisposing genes and probably several genes being involved in the diseases process. In addition, an interesting observation in both pedigrees described by Strom's group and one which is difficult to understand in terms of classical Mendelian genetics is that the disease tended to start progressively earlier over the generations (60 to 81 years in the grandparents, 36 to 47 in the parents, and 12 to 28 in the probands). For both families, the clinical details of the individuals suggested that not only was the disease starting earlier, but it was also becoming more severe over the generations.' Is there any possible explanation for this observation, and does this anecdote have any potential repercussions for our understanding of the genetics of the rheumatic diseases?
There are a number of monogenic diseases in which various aspects of increasing severity and earlier age of onset from generation to generation (an epidemiological observation known as 'genetic anticipation') are now Similarly, unstable trinucleotide repeats have been described in the other diseases listed above. There are many unanswered questions, both as to what defect in DNA replication leads to these expansions, and as to how the increases in copy numbers lead to disease phenotypes. However, in the diseases listed there is variable evidence of a direct correlation between the size of the expansion and the severity of the disease, and an inverse correlation with the age of onset.9 '5 Molecular biology has provided an objective marker of the epidemiological observation of anticipation in these monogenic diseases.
The majority of common rheumatological diseases, such as RA, are not monogenic in their aetiology, with multicase families such as the two pedigrees described by Strom et al being the exception rather than the rule. Is there any evidence that genetic anticipation operates in genetically more complex diseases? Disorders in which the aetiology is multifactorial, and yet in familial cases there is good evidence for increasing severity and decreasing age of onset over the generations include bipolar affective disorder,'6 schizophrenia,'7 testicular germ cell tumours,'8 and hypertrophic cardiomyopathy. '9 In these diseases, the epidemiological evidence for genetic anticipation is already leading to searches for unstable genetic elements, such as expanded trinucleotide repeats, which might account for at least part of their genetic aetiology.
The ? Parental ages at proband conception influence proband age of onset in familial RA24 ? Disease becomes more severe and starts earlier in consecutively affected generations' 24 restricted to the two families described by Strom et al, but may occur in most families in which consecutive generations are affected. 24 We also suggest that within pedigrees in which mothers and offspring are affected by RA, the parental ages of conception may have predictive value in the proband age of RA onset. 24 As has been argued exhaustively over this century with respect to myotonic dystrophy, these observations are prone to ascertainment bias and need to be confirmed in larger and more detailed studies. However, we feel that our first step in this direction has been sufficiently encouraging to warrant further epidemiological studies, as well as searches for unstable genetic elements in the DNA of families with evidence of vertical disease transmission. The epidemiology is equally applicable to other multifactorial musculoskeletal diseases, such as familial forms of osteoarthritis and the seronegative spondarthropathies.
Our understanding of the complexities of molecular biology is proceeding rapidly. A recent review drew the attention of rheumatologists to two newly recognised genetic mechanisms that may be relevant in musculoskeletal disease:27 genetic imprinting, in which the parental origin of an allele is critical in its expression, and X chromosome inactivation, with which differences in the proportion of parental X chromosomes inactivated in females may be influential in 
